tiprankstipranks
Trending News
More News >
Target Healthcare REIT Limited (GB:THRL)
LSE:THRL
UK Market

Target Healthcare REIT (THRL) AI Stock Analysis

Compare
40 Followers

Top Page

GB:THRL

Target Healthcare REIT

(LSE:THRL)

Select Model
Select Model
Select Model
Outperform 71 (OpenAI - 4o)
Rating:71Outperform
Price Target:
103.00p
▲(5.86% Upside)
The overall stock score is driven by a solid valuation with a low P/E ratio and high dividend yield, despite concerns over declining cash flow growth and weak technical momentum.
Positive Factors
Stable Revenue Growth
Stable revenue growth indicates consistent demand for healthcare properties, supporting long-term income stability and potential capital appreciation.
Balanced Financial Structure
A balanced financial structure with moderate leverage enhances financial stability, providing flexibility for future investments and growth.
Strong Cash Generation
Strong cash generation supports the company's ability to fund operations, pay dividends, and invest in growth opportunities, ensuring long-term sustainability.
Negative Factors
Declining Cash Flow Growth
Declining cash flow growth may limit the company's ability to invest in new properties or return capital to shareholders, potentially impacting future growth.
Operational Efficiency Concerns
Declining margins suggest potential inefficiencies or cost pressures, which could affect profitability and competitiveness in the long term.
Declining Cash Flow Growth
Reduced cash flow growth and efficiency issues may hinder the company's ability to maintain its current financial performance and pursue strategic initiatives.

Target Healthcare REIT (THRL) vs. iShares MSCI United Kingdom ETF (EWC)

Target Healthcare REIT Business Overview & Revenue Model

Company DescriptionTarget Healthcare REIT provide a range of tailored funding solutions to support operators to increase the provision of modern, purpose-built care homes across the UK.
How the Company Makes MoneyTarget Healthcare REIT generates revenue primarily through rental income from its portfolio of healthcare properties. The company leases these properties to experienced operators under long-term agreements, ensuring a stable and predictable income stream. Additionally, THRL benefits from property appreciation over time, which can enhance its overall asset value. The REIT may also engage in strategic partnerships with healthcare operators to optimize the performance of its properties, contributing to its financial performance. The demand for healthcare services and the growing need for specialized facilities further support the company's revenue potential.

Target Healthcare REIT Financial Statement Overview

Summary
Target Healthcare REIT shows stable revenue growth and profitability with a balanced financial structure. However, declining cash flow growth and operational efficiency are concerns.
Income Statement
75
Positive
The income statement shows a stable revenue growth rate of 3.07% in the latest year, with strong gross and net profit margins. However, there is a noticeable decline in EBIT and EBITDA margins compared to previous years, indicating potential pressure on operational efficiency.
Balance Sheet
70
Positive
The balance sheet reflects a moderate debt-to-equity ratio, indicating a balanced leverage position. The return on equity has been positive, although it has shown some fluctuations. The equity ratio remains healthy, suggesting a stable financial structure.
Cash Flow
65
Positive
Cash flow analysis reveals a decline in free cash flow growth, which could be a concern. However, the operating cash flow to net income ratio remains strong, indicating efficient cash generation relative to earnings.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue72.93M72.93M78.48M67.75M63.86M49.98M
Gross Profit64.84M64.84M78.48M60.14M56.55M44.18M
EBITDA59.59M59.59M58.00M0.000.000.00
Net Income60.84M60.84M73.02M-6.57M49.10M43.88M
Balance Sheet
Total Assets986.19M986.19M967.37M908.26M963.66M718.39M
Cash, Cash Equivalents and Short-Term Investments39.64M39.64M38.88M15.37M34.48M21.11M
Total Debt240.29M240.29M240.67M227.05M231.38M127.90M
Total Liabilities273.73M273.73M278.08M253.45M264.89M153.21M
Stockholders Equity712.46M712.46M689.29M654.81M698.77M565.18M
Cash Flow
Free Cash Flow41.10M41.10M42.34M29.66M30.39M24.96M
Operating Cash Flow41.10M41.10M42.34M29.66M30.39M24.96M
Investing Cash Flow-3.23M-3.23M3.42M-3.55M-202.63M-43.58M
Financing Cash Flow-37.11M-37.11M-22.24M-45.23M185.62M3.29M

Target Healthcare REIT Technical Analysis

Technical Analysis Sentiment
Positive
Last Price97.30
Price Trends
50DMA
94.78
Positive
100DMA
94.55
Positive
200DMA
94.65
Positive
Market Momentum
MACD
0.45
Negative
RSI
58.40
Neutral
STOCH
68.21
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:THRL, the sentiment is Positive. The current price of 97.3 is above the 20-day moving average (MA) of 95.81, above the 50-day MA of 94.78, and above the 200-day MA of 94.65, indicating a bullish trend. The MACD of 0.45 indicates Negative momentum. The RSI at 58.40 is Neutral, neither overbought nor oversold. The STOCH value of 68.21 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:THRL.

Target Healthcare REIT Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
1.73%21.53%
75
Outperform
£623.95M8.1610.16%3.87%13.95%-17.77%
74
Outperform
£2.53B13.377.01%7.28%0.96%
73
Outperform
16.01%
71
Outperform
9.828.68%6.15%4.86%-16.65%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:THRL
Target Healthcare REIT
97.30
19.27
24.70%
GB:AGR
Assura plc
47.48
11.48
31.89%
GB:PHP
Primary Health Properties plc R.E.I.T
97.20
11.85
13.88%
GB:WHR
Warehouse REIT PLC
113.00
37.37
49.41%
GB:PRSR
PRS REIT Plc
113.60
10.18
9.84%

Target Healthcare REIT Corporate Events

Regulatory Filings and Compliance
Target Healthcare REIT Updates Voting Rights Structure
Neutral
Apr 10, 2025

Target Healthcare REIT PLC announced a change in its voting rights structure following an acquisition or disposal by Waverton Investment Management Limited. The notification indicates that Waverton now holds 3.04% of the voting rights, totaling 18,869,630 shares, which may impact the company’s governance and decision-making processes.

Spark’s Take on GB:THRL Stock

According to Spark, TipRanks’ AI Analyst, GB:THRL is a Outperform.

Target Healthcare REIT demonstrates strong financial performance and valuation metrics, with a stable dividend yield and attractive P/E ratio. The technical analysis suggests positive momentum, though caution is advised due to overbought indicators. Recent corporate activities further support a positive sentiment, positioning the company well for future growth.

To see Spark’s full report on GB:THRL stock, click here.

Business Operations and StrategyFinancial Disclosures
Target Healthcare REIT to Present Interim Results Live
Positive
Mar 26, 2025

Target Healthcare REIT PLC announced a live presentation of its Interim Results by Kenneth MacKenzie and James MacKenzie from Target Fund Managers. The presentation, scheduled for 1 April 2025, is accessible to all existing and potential shareholders, allowing them to engage and submit questions. This initiative aims to enhance transparency and engagement with stakeholders, potentially impacting investor relations positively.

Business Operations and StrategyFinancial Disclosures
Target Healthcare REIT Reports Strong Half-Year Results with Growth in Earnings and Portfolio Valuation
Positive
Mar 14, 2025

Target Healthcare REIT plc reported a strong performance for the six months ending December 2024, with a 1.8% increase in EPRA NTA per share and a 4.5% total accounting return. The company has maintained a robust balance sheet with long-term fixed-rate debt and a fully covered growing dividend. The portfolio’s market valuation rose by 1.8%, driven by rental uplifts and capital expenditure, while maintaining a high occupancy rate and strong rent collection. The company benefits from sectoral tailwinds such as an aging population and a trend towards quality care homes, positioning it well for future growth.

Business Operations and StrategyFinancial Disclosures
Target Healthcare REIT to Announce Half-Year Results
Neutral
Mar 11, 2025

Target Healthcare REIT announced it will release its half-year results for the period ending 31 December 2024 on 14 March 2025. The company emphasizes its strategy of building supportive relationships with tenants to enhance care standards and ensure stable returns, reflecting its commitment to sustainable business practices.

Business Operations and Strategy
Target Healthcare REIT Appoints Panmure Liberum as Joint Broker
Positive
Mar 5, 2025

Target Healthcare REIT has appointed Panmure Liberum Limited as a joint broker alongside its existing corporate broker, Stifel Nicolaus Europe Limited. This strategic move is expected to enhance the company’s market operations and potentially strengthen its industry positioning by leveraging the expertise of both brokers.

Other
BlackRock Increases Stake in Target Healthcare REIT
Positive
Mar 3, 2025

Target Healthcare REIT PLC has announced that BlackRock, Inc. has increased its holdings in the company, crossing the 5% threshold of voting rights. This acquisition by a major global investment firm like BlackRock could signal confidence in Target Healthcare’s market position and potential for growth, potentially impacting investor sentiment positively.

Business Operations and StrategyRegulatory Filings and Compliance
BlackRock Adjusts Stake in Target Healthcare REIT Below 5%
Neutral
Feb 10, 2025

The notification indicates that BlackRock, Inc. has adjusted its holdings in Target Healthcare REIT PLC, with its voting rights now falling below 5%. This change reflects BlackRock’s ongoing portfolio management strategy and may influence the market perception of Target Healthcare REIT’s stock, potentially affecting investor sentiment and trading activity.

DividendsFinancial Disclosures
Target Healthcare REIT Reports NAV Growth and Declares Dividend
Positive
Feb 5, 2025

Target Healthcare REIT announced a 0.9% increase in its EPRA Net Tangible Assets per share, driven by inflation-linked rent reviews, and declared a second interim dividend. The company maintains a positive outlook due to demographic trends and demand for modern care homes, with a stable rent cover and strong tenant base supporting its long-term returns.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 11, 2025